519 related articles for article (PubMed ID: 17459670)
1. TRPC6 and FSGS: the latest TRP channelopathy.
Mukerji N; Damodaran TV; Winn MP
Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
[TBL] [Abstract][Full Text] [Related]
2. 2007 Young Investigator Award: TRP'ing into a new era for glomerular disease.
Winn MP
J Am Soc Nephrol; 2008 Jun; 19(6):1071-5. PubMed ID: 18434567
[TBL] [Abstract][Full Text] [Related]
3. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
4. [The genetic basis of familial focal segmental glomerulosclerosis and related nephrotic syndrome].
Tsukaguchi H; Kitamura A
Nihon Jinzo Gakkai Shi; 2007; 49(2):88-97. PubMed ID: 17375615
[No Abstract] [Full Text] [Related]
5. R168H and V165X mutant podocin might induce different degrees of podocyte injury via different molecular mechanisms.
Fan Q; Zhang H; Ding J; Liu S; Miao J; Xing Y; Yu Z; Guan N
Genes Cells; 2009 Sep; 14(9):1079-90. PubMed ID: 19674119
[TBL] [Abstract][Full Text] [Related]
6. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
7. Focal segmental glomerulosclerosis: molecular genetics and targeted therapies.
Chen YM; Liapis H
BMC Nephrol; 2015 Jul; 16():101. PubMed ID: 26156092
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.
Löwik MM; Groenen PJ; Levtchenko EN; Monnens LA; van den Heuvel LP
Eur J Pediatr; 2009 Nov; 168(11):1291-304. PubMed ID: 19562370
[TBL] [Abstract][Full Text] [Related]
9. New TRPC6 gain-of-function mutation in a non-consanguineous Dutch family with late-onset focal segmental glomerulosclerosis.
Hofstra JM; Lainez S; van Kuijk WH; Schoots J; Baltissen MP; Hoefsloot LH; Knoers NV; Berden JH; Bindels RJ; van der Vlag J; Hoenderop JG; Wetzels JF; Nijenhuis T
Nephrol Dial Transplant; 2013 Jul; 28(7):1830-8. PubMed ID: 23291369
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol.
Anderson M; Kim EY; Hagmann H; Benzing T; Dryer SE
Am J Physiol Cell Physiol; 2013 Aug; 305(3):C276-89. PubMed ID: 23657570
[TBL] [Abstract][Full Text] [Related]
11. Screening of ACTN4 and TRPC6 mutations in a Chinese cohort of patients with adult-onset familial focal segmental glomerulosclerosis.
Zhang Q; Ma J; Xie J; Wang Z; Zhu B; Hao X; Yang L; Ren H; Chen N
Contrib Nephrol; 2013; 181():91-100. PubMed ID: 23689571
[TBL] [Abstract][Full Text] [Related]
12. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.
Barua M; Brown EJ; Charoonratana VT; Genovese G; Sun H; Pollak MR
Kidney Int; 2013 Feb; 83(2):316-22. PubMed ID: 23014460
[TBL] [Abstract][Full Text] [Related]
14. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
[TBL] [Abstract][Full Text] [Related]
15. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
16. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L
Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213
[TBL] [Abstract][Full Text] [Related]
17. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.
Dryer SE; Reiser J
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F689-701. PubMed ID: 20685822
[TBL] [Abstract][Full Text] [Related]
18. Slit or pore? A mutation of the ion channel TRPC6 causes FSGS.
Walz G
Nephrol Dial Transplant; 2005 Sep; 20(9):1777-9. PubMed ID: 15998650
[No Abstract] [Full Text] [Related]
19. Gq signaling causes glomerular injury by activating TRPC6.
Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
[TBL] [Abstract][Full Text] [Related]
20. [Focal segmental glomerulosclerosis].
Yuzawa Y; Matsuo S
Nihon Rinsho; 2004 Oct; 62(10):1837-41. PubMed ID: 15500127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
